IPSC
NASDAQ · Biotechnology
Century Therapeutics Inc
$2.45
+0.04 (+1.66%)
Open$2.38
Previous Close$2.41
Day High$2.55
Day Low$2.34
52W High$3.04
52W Low$0.44
Volume—
Avg Volume914.7K
Market Cap418.42M
P/E Ratio—
EPS$-1.11
SectorBiotechnology
Analyst Ratings
Strong Buy
12 analysts
Price Target
+1,016.3% upside
Current
$2.45
$2.45
Target
$27.35
$27.35
$22.03
$27.35 avg
$42.34
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 227.46M | 24.41M | 24.82M |
| Net Income | -19,965,277 | -1,389,193 | -1,166,783 |
| Profit Margin | -8.8% | -5.7% | -4.7% |
| EBITDA | -8,693,101 | -1,777,503 | -1,974,923 |
| Free Cash Flow | — | -1,484,406 | -1,631,995 |
| Rev Growth | +175.9% | +22.2% | +16.0% |
| Debt/Equity | — | 0.27 | 0.31 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $251.64 | -1.05% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $362.12 | +0.44% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.34 | +0.01% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $496.73 | -0.58% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $623.54 | -1.31% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $301.03 | +2.56% | 69.3 | 39.97B |